Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | APUS | PASG | ||
| Company | Cara Therapeutics | Apimeds Pharmaceuticals US Inc | Passage Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 16.17 | 1.8900 | 7.29 | ||
| High | 16.56 | 1.8900 | 7.29 | ||
| Low | 15.84 | 1.6000 | 6.76 | ||
| Latest | 15.96 | 1.7400 | 6.93 | ||
| Change | -0.69 | -0.2100 | -0.11 | ||
| % Change | -4.14% | -10.77% | -1.49% | ||
| Volume | 79,033 | 65,492 | 18,867 | ||
| 20-Day Average Volume | 30,465 | 92,408 | 43,293 | ||
| Previous Close | 16.65 | 1.9500 | 7.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.16 | 1.5240 | 8.05 | ||
| 20-Day Raw Stochastic | 65.04% | 63.47% | 5.70% | ||
| 20-Day Relative Strength | 54.57 | 55.07 | 37.65 | ||
| Weighted Alpha | -27.45 | -29.14 | -46.26 | ||
| Today's Opinion | 100% Buy | 40% Sell | 40% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 72% Buy | 72% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.69% since 04/08/25 | +7.80% since 03/17/26 | -5.90% since 03/17/26 | ||
| Low | 4.71 on 04/09/25 | 1.5100 on 03/18/26 | 6.76 on 03/24/26 | ||
| High | 5.75 on 04/14/25 | 2.1000 on 03/20/26 | 7.68 on 03/18/26 | ||
| 1-Month | |||||
| %Chg | +3.70% since 03/14/25 | +36.60% since 02/24/26 | -25.27% since 02/24/26 | ||
| Low | 4.52 on 04/07/25 | 1.2500 on 03/02/26 | 6.76 on 03/24/26 | ||
| High | 5.75 on 04/14/25 | 2.1000 on 03/20/26 | 9.83 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +19.28% since 01/15/25 | +1.68% since 12/24/25 | -36.32% since 12/24/25 | ||
| Low | 4.30 on 03/05/25 | 0.9510 on 02/13/26 | 6.76 on 03/24/26 | ||
| High | 6.00 on 01/27/25 | 3.0000 on 01/23/26 | 20.00 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +73.86% since 10/15/24 | -4.51% since 09/24/25 | -10.11% since 09/24/25 | ||
| Low | 2.71 on 12/18/24 | 0.9510 on 02/13/26 | 6.15 on 11/07/25 | ||
| High | 6.36 on 12/31/24 | 4.0310 on 11/17/25 | 20.00 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,332 | 24,523 | 22,583 | ||
| Shares Outstanding, K | 4,574 | 12,576 | 3,208 | ||
| Annual Sales | 7,140,000 | 0 | 0 | ||
| Annual Net Income | -70,870,000 | -1,390,000 | -45,520,000 | ||
| Last Quarter Sales | 1,460,000 | 0 | 0 | ||
| Last Quarter Net Income | -7,680,000 | -1,780,000 | -12,980,000 | ||
| 60-Month Beta | 0.41 | N/A | 1.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.80 on 11/14/24 | -0.14 on 11/12/25 | -4.08 on 03/03/26 | ||
| Latest Earnings Date | 05/12/25 | 04/21/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||